CORE LABS INC (CLB)
(Delayed Data from NYSE)
$22.63 USD
-0.27 (-1.18%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $22.63 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CLB 22.63 -0.27(-1.18%)
Will CLB be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CLB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CLB
FMC Technologies (FTI) Reports Next Week: Wall Street Expects Earnings Growth
What's in Store for Core Laboratories (CLB) in Q2 Earnings?
CLB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Core Laboratories (CLB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
BKR or CLB: Which Is the Better Value Stock Right Now?
Core Laboratories (CLB) Up 6.2% Since Last Earnings Report: Can It Continue?
Other News for CLB
Candy Club Shareholders Approve Key Resolutions
Gateway Group Announces Preliminary Sponsors and Additional Presenting Companies for September Gateway Conference
Christina Lake Cannabis Announces Filing of Q1 Financial Statements
CORE LABORATORIES' SECOND QUARTER 2024 WEBCAST AT 7:30 A.M. CDT / 8:30 A.M. EDT ON JULY 25, 2024
Ariel Investments Focused Value Q1 2024 Commentary